Sam Molyneux

Co-CEO & Co-founder @Poppy

San Francisco, CA, US
EMAILS
s•••@poppy.com
MOBILE NUMBERS
+19•••••••68

Signup · Get unlimited contacts

WORK HISTORY

Sep 2019 — Present

Co-CEO & Co-founder @Poppy

View department →

Toronto, ON, CA

Founded in 2019, Poppy is a startup company located in San Francisco and Toronto. We are backed by institutional venture investors, along with some of my favorite people in the whole wide world.

EDUCATION

2006 — 2013

University of Toronto

Doctor of Philosophy (PhD), Medical Biophysics (I still need to defend)

2000 — 2005

Queen's University

Bachelor of Science (BSc), Honours, Biochemistry

SKILLS

Data AnalysisFunctional GenomicsMolecular BiologyBioinformaticsCancer ResearchMolecular GeneticsResearch InformationInformation TechnologyStartupsCancer GenomicsCell BiologyWestern BlottingGenomicsLifesciencesStart-UpsBiochemistryCancerPcrCell CultureGeneticsSequencingSystems BiologyBiotechnologyEntrepreneurshipStrategyCellStem CellsLife SciencesScientific WritingResearch

ABOUT SAM MOLYNEUX

Sam is an experienced entrepreneur and scientist specializing in bringing mission-driven, deep technology ventures to market.Sam is Co-Founder and Co-CEO of Poppy, an institutional venture-backed technology company located in San Francisco and Toronto. Poppy was named 5th on the Top 10 Most Innovative Companies in the World list alongside Ford and Samsung in 2022, and is pioneering a new global standard in indoor health and sustainability in buildings. He previously co-founded Meta, an early artificial intelligence company. In 2017, Meta was acquired by the Chan Zuckerberg Initiative to make its technologies and data freely available to the world. In 2021, Meta was used to help rebrand Facebook Inc, providing a home brand for Fb, Instagram, WhatsApp and Reality Labs. Sam has received several honours for his work in science and business, including Canada’s Top 40 Under 40. Sam was named #20 on Fast Company Magazine’s 100 Most Creative People in Business in 2017. In 2016, he won the Martin Walmsley Fellowship Award, and previously the Banting & Best Doctoral Fellowship.Meta was recognized as one of the Top 10 Innovations of 2014 by The Scientist Magazine, and has been written about in MIT Technology Review, TechCrunch, The Economist, Fortune, ReCode, Engadget, Wired, Bloomberg, CNBC, CNN, NewsWeek, and Communications of the ACM among others. Meta’s acquisition by the Chan Zuckerberg Initiative was covered in more than 160 news and magazine outlets.Sam’s research has been published in Nature Genetics, Nature Cell Biology, Science Translational Medicine, Cancer Cell, PNAS, and JCI, among others.He is a frequent speaker on scientific information and technology for good, and for three years running, on AI for Good at the United Nations.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.